Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 228.5% in October

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 56,500 shares, a growth of 228.5% from the September 30th total of 17,200 shares. Based on an average daily trading volume, of 58,800 shares, the days-to-cover ratio is presently 1.0 days.

Fresenius SE & Co. KGaA Stock Performance

OTCMKTS:FSNUY traded down $0.03 during mid-day trading on Friday, reaching $9.11. The company’s stock had a trading volume of 25,057 shares, compared to its average volume of 27,428. The stock has a market cap of $20.34 billion, a P/E ratio of 12.24 and a beta of 1.05. The company has a current ratio of 1.29, a quick ratio of 1.00 and a debt-to-equity ratio of 0.56. The firm’s fifty day moving average price is $9.28 and its two-hundred day moving average price is $8.39. Fresenius SE & Co. KGaA has a 12-month low of $6.33 and a 12-month high of $9.78.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.22 earnings per share (EPS) for the quarter. The company had revenue of $5.83 billion during the quarter. On average, equities analysts forecast that Fresenius SE & Co. KGaA will post 0.84 EPS for the current fiscal year.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.